RT Journal Article
SR Electronic
T1 Mortality Analysis of COVID-19 Confirmed Cases in Pakistan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.07.20121939
DO 10.1101/2020.06.07.20121939
A1 Chaudhry, Ambreen
A1 Ikram, Aamer
A1 Baig, Mirza Amir
A1 Salman, Muhammad
A1 Ghafoor, Tamkeen
A1 Zakir, Hussain
A1 Khan, Mumtaz Ali
A1 Ansari, Jamil Ahmed
A1 Syed, Asif
A1 Javed, Wasif
A1 Larik, Ehsan
A1 Mohsan, Muhammad
A1 Masood, Naveed
A1 Iqbal, Zeeshan
A1 Akram, Khurram
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.06.07.20121939.abstract
AB Introduction COVID-19, a novel disease, appeared in December 2019 in China and rapidly spread across the world. Till second week of April 2020, high incidence (2.9/100,000) and cases fatality rates (1.7%)was observed in Pakistan.This study was conducted to determine temporal and spatial distribution of first 100 deaths attributed to COVID-19 in Pakistan and their associated demographic factors.Method We conducted a descriptive epidemiological analysis of first 100 deaths reported among RT-PCR confirmed COVID-19 cases. Demographic, epidemiological and risk factors information was obtained associated comorbidities and clinical signs and symptoms were recorded and frequencies were determined.Results A total of 100 mortalities with overall Case Fatality Rate 1.67% (CFR) were analysed. Median age of patients was 64.5 years (IQR: 54–70) with 75% (n = 75) Males. Among all deaths reported, 71 (71%) cases had one or more documented comorbidities at the time of diagnosis. Most frequently reported co-morbidities were; hypertension (67 %), followed by Diabetes Mellitus 945%) and Ischemic Heart Diseases (27%). First death was reported on 18 March 2020 and the most frequent presenting symptoms were shortness of breath (87%) and fever (79%). Median duration of illness was eight days (IQR: 4–11 days), median delay reaching hospital to seek health care was three days (IQR: 0–6 days) while median duration of hospital stay was also three days (IQR: 1–7 days). Among all reported deaths, 62% were attributed to local transmission as these cases had no history of international travel. The most affected age group was 60–69 years while no death reported in age group below 20 years.Conclusion High CFR among old age group and its association with co-morbidities (chronic disease) suggests targeted interventions such as social distancing and strict quarantine measure for elderly and morbid people. Comparative studies among deaths and recovered patients are recommended to explore further disease dynamics.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Institute of Health has approved the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on request, subject to the approval of National Institute of Health of Pakistan